<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://majorhealthnews.com/press-releases/inhibrx-reports-third-quarter-2026-financial-results</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T21:04:18.393Z</news:publication_date><news:title>Inhibrx Reports Third Quarter 2026 Financial Results</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/pei-wei-turns-up-heat-with-launch-of-limited-time-noodle-dish</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T16:19:20.995Z</news:publication_date><news:title>Pei Wei Turns Up Heat with Launch of Limited Time Noodle Dish</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/concierge-medicine-of-boca-raton-welcomes-dr-elizabeth-polsinelli-expanding-its-team-of</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T15:20:52.998Z</news:publication_date><news:title>Concierge Medicine of Boca Raton Welcomes Dr. Elizabeth Polsinelli, Expanding Its Team of Board-Certified Physicians</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/sino-biological-launches-4risetm-high-throughput-wet-lab-services-to-accelerate-ai-driven</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-13T15:10:16.078Z</news:publication_date><news:title>Sino Biological Launches 4RISE™ High-Throughput Wet-Lab Services to Accelerate AI-Driven Drug Discovery</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/new-phase-3b-data-on-lillys-taltz-ixekizumab-and-zepbound-tirzepatide-used-together</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T15:08:54.085Z</news:publication_date><news:title>New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy, patient-reported and metabolic outcomes at one year in adults with psoriatic arthritis and obesity</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/amgen-announces-positive-phase-3-results-for-dazodalibep-in-sjogrens-disease</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T13:13:57.122Z</news:publication_date><news:title>AMGEN ANNOUNCES POSITIVE PHASE 3 RESULTS FOR DAZODALIBEP IN SJÖGREN'S DISEASE</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/context-therapeutics-reports-third-quarter-2026-financial-results-and-pipeline-progress</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-10T21:39:35.141Z</news:publication_date><news:title>Context Therapeutics Reports Third Quarter 2026 Financial Results and Pipeline Progress</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/dominari-reports-q3-2026-results</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-10T13:08:35.627Z</news:publication_date><news:title>Dominari Reports Q3 2026 Results</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/city-therapeutics-announces-first-participant-dosed-in-phase-1-clinical-trial-of-city</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-10T12:31:05.750Z</news:publication_date><news:title>City Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of CITY-RBP4 for the Treatment of Stargardt Disease</news:title></news:news></url>
<url><loc>https://majorhealthnews.com/press-releases/cullinan-therapeutics-provides-corporate-update-and-reports-third-quarter-2026-financial</loc><news:news><news:publication><news:name>Major Health News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-10T12:20:22.715Z</news:publication_date><news:title>Cullinan Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results</news:title></news:news></url>
</urlset>